CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 244 enrolled
Drug / intervention
Standard pancreatoduodenectomy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00679913
NCT00679913Phase 3Completed
CompareCT.gov

Randomized Controlled Study: Comparison Between Extended and Standard Pancreatoduodenectomy

Seoul National University Hospital·interventional·Posted May 19, 2008·Updated Jun 6, 2014

In Brief

A Phase 3 clinical trial evaluating Standard pancreatoduodenectomy and Extended pancreatoduodenectomy for Pancreatic Cancer. Completed, enrolled 244 participants across 1 site.

Detailed Summary

This study was designed to test the hypothesis that more extensive nodal and soft-tissue clearance in patients with adenocarcinoma of the head of the pancreas would improve survival without an increase in morbidity and mortality.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cancer
CountriesSouth Korea
Collaborators--

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 19, 2008
Enrollment StartNov 1, 2005
Primary CompletionDec 1, 2012
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7.1 yearsPosted 18.1 years ago

Interventions

Standard pancreatoduodenectomyprocedure

Standard pancreatoduodenectomy

Extended pancreatoduodenectomyprocedure

Extended pancreatoduodenectomy